
Global report - September 4, 2017
Pfizer’s patent criticized
The pharma giant was recently granted a patent on their vaccine for pneumonia in India, which has been highly questioned by for example Medecins sans Frontiers (MSF). The patent approval means that other pharma companies are not allowed to manufacture cheaper versions of the vaccine and this is a major backlash in the fight for […]